Pharma-Bio Serv (PBSV) Total Debt (2020 - 2021)
Pharma-Bio Serv (PBSV) posted Total Debt of $1.9 million for Q2 2021, little changed on a QoQ basis from $1.9 million in Q1 2021, and little changed year-over-year from $1.9 million in Q2 2020.
Pharma-Bio Serv (PBSV) Total Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv's Total Debt history runs 2 years deep, the most recent figure standing at $1.9 million for Q2 2021.
- Quarterly Total Debt changed 0.0% year-over-year to $1.9 million in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $1.9 million (changed 0.0% YoY) and the FY2020 annual result came in at $1.9 million, changed N/A from the prior year.
- Total Debt was $1.9 million for Q2 2021 at Pharma-Bio Serv, roughly flat from $1.9 million in the prior quarter.
- Across five years, Total Debt topped out at $1.9 million in Q2 2020 and bottomed at $1.9 million in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.97 Bn | 24.65 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.72 Bn | 13.82 Bn | 482.22 Mn | 2.50 Bn |
| 3 | Healthequity | 8.31 Bn | 8.05 Bn | 256.31 Mn | 942.66 Mn |
| 4 | Hinge Health | 5.99 Bn | 5.68 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn | - |
| 6 | MiniMed | 4.54 Bn | 4.24 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.48 Bn | 4.42 Bn | 216.84 Mn | 1.47 Bn |
| 8 | Doximity | 3.96 Bn | 3.21 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.15 Bn | 2.73 Bn | - | - |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 1.93 Mn |
| Jan 31, 2021 | 1.93 Mn |
| Oct 31, 2020 | 1.93 Mn |
| Jul 31, 2020 | 1.93 Mn |
| Apr 30, 2020 | 1.93 Mn |